Mark Dybul
2022
In 2022, Mark Dybul earned a total compensation of $10.8M as Chief Executive Officer at Enochian Biosciences, a 2,400% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $9,801,000 |
| Salary | $850,000 |
| Total | $10,751,000 |
Dybul received $9.8M in option awards, accounting for 91% of the total pay in 2022.
Dybul also received $100K in bonus and $850K in salary.
Rankings
In 2022, Mark Dybul's compensation ranked 224th out of 5,760 executives tracked by ExecPay. In other words, Dybul earned more than 96.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 224 out of 5,760 | 96th |
Division Manufacturing | 84 out of 3,136 | 97th |
Major group Chemicals And Allied Products | 16 out of 1,422 | 99th |
Industry group Drugs | 12 out of 1,323 | 99th |
Industry Pharmaceutical Preparations | 9 out of 969 | 99th |
Source: SEC filing on May 16, 2023.
Dybul's colleagues
We found one more compensation record of an executive who worked with Mark Dybul at Enochian Biosciences in 2022.
2022
Luisa Puche
Enochian Biosciences